- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Remus Pharmaceuticals Limited — Important, 24-07-2025: General Updates
24-07-2025 | 02:53 pm
24-07-2025 | 02:53 pm
REMUS has successfully incorporated its new subsidiary, Espee Global Clinical Trial Services Private Limited. This marks a significant business development, officially establishing the entity under the Companies Act. This expansion builds on the previously announced approval, enhancing the company's operational capabilities and potential for future growth in clinical trial services.
No comments yet. Be the first to comment!